United States
Germany
Japan
United Kingdom
China
TNFRSF8 mouse monoclonal antibody, clone OTI1C6 (formerly 1C6)
| Applications | FC, WB |
| Reactivities | Human |
Products
TNFRSF8 mouse monoclonal antibody, clone OTI16H5 (formerly 16H5)
| Applications | FC, WB |
| Reactivities | Human |
TNFRSF8 mouse monoclonal antibody, clone OTI1C6 (formerly 1C6)
| Applications | FC, WB |
| Reactivities | Human |
TNFRSF8 mouse monoclonal antibody, clone OTI16H5 (formerly 16H5)
| Applications | FC, WB |
| Reactivities | Human |
TNFRSF8 (CD30) mouse monoclonal antibody,clone UMAB256
| Applications | 10k-ChIP, IHC, WB |
| Reactivities | Human |
TNFRSF8 mouse monoclonal antibody, clone OTI18D3 (formerly 18D3)
| Applications | FC, WB |
| Reactivities | Human |
TNFRSF8 mouse monoclonal antibody, clone OTI9H7 (formerly 9H7)
| Applications | FC, WB |
| Reactivities | Human |
TNFRSF8 (Myc-DDK-tagged)-Human tumor necrosis factor receptor superfamily, member 8 (TNFRSF8), transcript variant 1
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
TNFRSF8 mouse monoclonal antibody, clone OTI2G7 (formerly 2G7)
| Applications | FC |
| Reactivities | Human |
TNFRSF8 (CD30) mouse monoclonal antibody,clone UMAB256
| Applications | 10k-ChIP, IHC, WB |
| Reactivities | Human |
TNFRSF8 mouse monoclonal antibody, clone OTI3A2 (formerly 3A2)
| Applications | FC, WB |
| Reactivities | Human |
TNFRSF8 mouse monoclonal antibody,clone OTI3F8
| Applications | FC, WB |
| Reactivities | Human |
TNFRSF8 mouse monoclonal antibody, clone OTI3B10 (formerly 3B10)
| Applications | FC, WB |
| Reactivities | Human |
TNFRSF8 mouse monoclonal antibody, clone OTI18D3 (formerly 18D3)
| Applications | FC, WB |
| Reactivities | Human |
TNFRSF8 mouse monoclonal antibody, clone OTI3B5 (formerly 3B5)
| Applications | FC, WB |
| Reactivities | Human |
